Stock Events

Stock Events

Telomir Pharmaceuticals (TELO) Q3 2025 Earnings

14AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.2

-0.16

-0.11

-0.07

Details

Expected EPS

-0.08

Actual EPS

N/A

Surprise EPS

0.08

Surprise Percent

+100%

Description

Telomir Pharmaceuticals (TELO) will report earnings of for Q3 2025 on August 14, 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.